[1]
C. . Freese, M. Sudhoff, L. . Lewis, M. . Lamba, and J. . Kharofa, “The volume of PET-defined, active bone marrow spared predicts acute hematologic toxicities in anal cancer patients receiving concurrent chemoradiotherapy”, AO, vol. 57, no. 5, pp. 683–686, May 2018.